Multiplier AI Blog
Know How Data, AI, & Digital Marketing Can Help Pharma & Life Sciences
Why Pharma CRMs Fail at Consent Tracking ?
Most pharma companies believe their CRM systems are ready for DPDP compliance. After all, consent fields exist, opt out flags are present, and suppression lists are maintained. On paper, this looks sufficient.
Consent Enforcement at the Point of Engagement: What Pharma Must Do?
Most pharma companies believe they are compliant because consent exists somewhere in their CRM or databases. Under the Digital Personal Data Protection Act 2023, that belief is not enough.
DPDP-Compliant Consent Collection Across Email, WhatsApp, and Ads
Consent collection becomes significantly more complex when pharma marketing moves beyond a single channel. While many teams focus on capturing consent at a high level, real compliance challenges emerge during execution across email, WhatsApp, and digital advertising.
How to Capture Explicit Consent from Doctors at Scale ?
Capturing explicit consent from doctors has become one of the most difficult operational challenges for pharma marketing teams under the Digital Personal Data Protection Act 2023.
Why Opt In Is Not Enough Under DPDP Act in Pharma?
Opt-in built pharma's marketing engine. The DPDP Act 2023 just rewrote the rules. Here's why opt-in alone no longer counts as consent.
Explicit Consent vs Opt In: DPDP Perspective for Pharma
Explicit consent" and "opt-in" sound the same — under the DPDP Act 2023, they aren't. Here's what pharma marketing teams need to know.
Who Is the Data Principal Under DPDP Act: Doctor, Patient, or Both?
One of the most common sources of confusion under the Digital Personal Data Protection Act 2023 is the concept of the data principal.
Compliance Expectations for Significant Data Fiduciaries in Healthcare Under DPDP
The Digital Personal Data Protection Act 2023 introduces a higher bar for organisations that process personal data at scale or in sensitive contexts.
Why Pharma Companies Qualify as Significant Data Fiduciaries Under DPDP?
The Digital Personal Data Protection Act 2023 introduces an important concept that many pharma companies have not yet fully internalised: the idea of a Significant Data Fiduciary.
Data Fiduciary Meaning Explained Using Doctor Data
The term data fiduciary appears frequently in discussions around the Digital Personal Data Protection Act 2023, yet it remains poorly understood within pharma organisations.
Are Pharma Companies Data Fiduciaries Under DPDP Act?
One of the most important and misunderstood questions under the Digital Personal Data Protection Act 2023 is whether pharmaceutical companies qualify as data fiduciaries.
Data Protection Bill vs DPDP Act: What Changed for Healthcare?
For several years, India’s healthcare and pharmaceutical sector operated in a state of regulatory anticipation.